INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAB4. A total of 7 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,903,450 | +22.6% | 5,000,000 | 0.0% | 0.02% | +25.0% |
| Q2 2023 | $3,998,350 | -3.8% | 5,000,000 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $4,156,550 | +9.8% | 5,000,000 | 0.0% | 0.02% | +11.1% |
| Q4 2022 | $3,784,450 | +0.2% | 5,000,000 | 0.0% | 0.02% | +5.9% |
| Q3 2022 | $3,777,000 | +17.7% | 5,000,000 | 0.0% | 0.02% | +21.4% |
| Q2 2022 | $3,209,000 | +4.6% | 5,000,000 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $3,068,000 | +1.9% | 5,000,000 | 0.0% | 0.01% | +9.1% |
| Q4 2021 | $3,012,000 | -0.6% | 5,000,000 | 0.0% | 0.01% | -15.4% |
| Q3 2021 | $3,030,000 | -11.4% | 5,000,000 | 0.0% | 0.01% | -18.8% |
| Q2 2021 | $3,421,000 | +6.2% | 5,000,000 | 0.0% | 0.02% | -11.1% |
| Q1 2021 | $3,220,000 | +6.1% | 5,000,000 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $3,036,000 | -12.4% | 5,000,000 | 0.0% | 0.02% | -18.2% |
| Q3 2020 | $3,465,000 | -3.8% | 5,000,000 | 0.0% | 0.02% | -12.0% |
| Q2 2020 | $3,602,000 | -17.1% | 5,000,000 | 0.0% | 0.02% | -26.5% |
| Q1 2020 | $4,345,000 | -34.7% | 5,000,000 | 0.0% | 0.03% | +3.0% |
| Q4 2019 | $6,649,000 | +46.6% | 5,000,000 | 0.0% | 0.03% | +32.0% |
| Q3 2019 | $4,537,000 | -9.2% | 5,000,000 | 0.0% | 0.02% | -10.7% |
| Q2 2019 | $4,998,000 | – | 5,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 27,943,000 | $20,241,000 | 1.72% |
| Worth Venture Partners, LLC | 1,569,000 | $1,134,000 | 0.56% |
| Context Capital Management, LLC | 1,985,000 | $1,424,000 | 0.55% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 16,703,000 | $12,060,000 | 0.28% |
| CSS LLC/IL | 6,825,000 | $4,985,000 | 0.28% |
| SILVERBACK ASSET MANAGEMENT LLC | 1,500,000 | $1,095,000 | 0.27% |
| Polar Asset Management Partners Inc. | 20,000,000 | $14,452,000 | 0.24% |
| Senvest Management, LLC | 5,000,000 | $3,621,000 | 0.23% |
| FARALLON CAPITAL MANAGEMENT LLC | 25,500,000 | $18,998,000 | 0.15% |
| LINDEN ADVISORS LP | 12,755,000 | $9,258,000 | 0.15% |